News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–29
Matches
29
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

29 matching headlines

Ticker or company: DHER34Main company stories
Clear
Latest

finance.yahoo.com Earnings

Danaher Stock: Is Wall Street Bullish or Bearish?

Down day candlestick chart by Bigc Studio via Shutterstock With a market cap of $143.3 billion, Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator that combines advanced science, technology, and industry-leading businesses to help customers address complex scientific and clinical challenges and accelerate innovations from discovery to delivery. With approximately 60,000 associates worldwide, the …

Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Can Danaher (DHR) Trade At A Discount After Its CEO Change?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Danaher stock now sits around US$194.78 after a weak earnings update and a leadership …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Danaher (DHR) CEO Transition, Buybacks, And Updated 2026 Outlook

Danaher Corporation recently reported second-quarter 2026 results showing higher sales and earnings versus a year earlier, confirmed modest third-quarter revenue growth guidance, completed multi-billion-dollar share repurchases, and announced that Executive Vice President Julie Sawyer Montgomery will become President and CEO on October 1, 2026, …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?

Danaher Corporation (NYSE:DHR) delivered second-quarter results on July 21, marked by core growth improving compared to the previous quarter, along with disciplined execution that drove high-single-digit adjusted EPS growth. Despite beating earnings estimates, raising its adjusted EPS guidance, and reporting improving trends in its …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher promotes Julie Sawyer Montgomery to CEO

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Name: Julie Sawyer Montgomery New title: CEO, Danaher Previous title: Executive vice president, diagnostics, Danaher Danaher has named Julie Sawyer Montgomery as …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer

Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (DHR) Could Be 16% Undervalued On Earnings And 2026 Revenue Guidance

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Danaher (DHR) has attracted investor attention after issuing third quarter 2026 revenue guidance of 2% to 3% growth, alongside detailing recent share repurchases …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (DHR) Stock Tries To Steady After A Sharp Post Earnings Selloff

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Danaher (NYSE:DHR) shares saw a sharp post earnings selloff, with heavy trading activity highlighting strong investor reaction. Following the drop, the stock closed near its daily highs, …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity

Shareholders in biotechnology, life sciences, and diagnostics solutions company Danaher (NYSE: DHR) have had an interesting week. Their stock crashed early in the week on the release of its second-quarter earnings, only to recover somewhat through the week and start Friday morning having declined …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says

Danaher's (DHR) Q2 results were mixed, with the lumpier part of its bioprocess consumables business PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?

Danaher (DHR) closed the last trading session at $179.01, gaining 0% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Don’t Quit on Danaher Stock After Horrific Earnings Reaction

To say Danaher Corp. had a downbeat reaction to earnings is an understatement. Danaher had its worst day in two decades on Tuesday after the life sciences and diagnostics company’s second-quarter earnings. Danaher expects core revenue (a metric that excludes things like currency and …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (DHR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, July 21, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Rachel VatnsdalPresident and Chief Executive Officer - Rainer BlairExecutive Vice President and Chief Financial Officer - Matt Gugino TAKEAWAYS Revenue -- $6.3 …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Danaher (DHR) Shares Are Falling Today

Why Danaher (DHR) Shares Are Falling Today What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) fell 13.3% in the morning session after it reported underwhelming second-quarter results. The negative reaction appeared to stem from underlying concerns about the company's profitability. While …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher forecasts 3%-4% 2026 core revenue growth and raises adjusted EPS to $8.45-$8.60 following Masimo close

Earnings Call Insights: Danaher (DHR) Q2 2026 MANAGEMENT VIEW * "We delivered a solid second quarter with better-than-expected revenue, earnings and cash flow" (President, CEO & Director Rainer Blair), adding, "Our Life Sciences businesses delivered their strongest quarter in several years" and "the earlier-than-expected …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Plummets After One Segment Comes In 'Surprisingly Soft'

Danaher stock plummeted Tuesday after reporting what one analyst called "surprisingly soft" bioprocessing sales. Continue Reading

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Q2 Earnings Call Highlights

Key Points Interested in Danaher Corporation? Here are five stocks we like better. Danaher beat Q2 expectations with sales of $6.3 billion, adjusted EPS of $1.94, and $1.3 billion in free cash flow. Core revenue rose 3% year over year, with management saying performance …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Compared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Danaher (DHR) reported revenue of $6.27 billion, up 5.5% over the same period last year. EPS came in at $1.94, compared to $1.80 in the year-ago quarter. The reported revenue represents a surprise of +2.88% over the Zacks …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (DHR) Q2 Earnings and Revenues Top Estimates

Danaher (DHR) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $1.8 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher shares tumble despite earnings beat

Investing.com -- Danaher Corporation (NYSE:DHR) reported second quarter results that exceeded analyst expectations, but shares fell 9% premarket. The company posted adjusted earnings per share of $1.94, beating the analyst consensus of $1.84 by $0.10. Revenue reached $6.3 billion, surpassing the $6.1 billion estimate …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops

Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops Diversified science and technology company Danaher (NYSE:DHR) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 5.5% year on year to $6.27 billion. Its non-GAAP profit of $1.94 per …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher Reports Second Quarter 2026 Results

WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 Results Net earnings were $870 …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danaher (DHR) Q2 Earnings Report Preview: What To Look For

Danaher (DHR) Q2 Earnings Report Preview: What To Look For Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here's what you need to know. Danaher missed analysts' revenue expectations last quarter, reporting revenues of $5.95 billion, …

DHER34 main company
Sharemaestro market context Price above Trend Line 52 weeks -7.5% DHER34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context